Stay updated with breaking news from Point Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
MILWAUKEE, Nov. 7, 2022 /PRNewswire/ -- Ademi LLP is investigating Oyster Point Pharma for possible breaches of fiduciary duty and other violations of law in its transaction with Viatris. ...
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
NEW YORK, Nov. 7, 2022 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential viola...
PRINCETON, N.J., Sept. 07, 2022 (GLOBE NEWSWIRE) -- Oyster Point Pharma, Inc., (Nasdaq: OYST), (“Oyster Point Pharma”, or “the Company”), a...
Press release content from Globe Newswire. The AP news staff was not involved in its creation.